Japanese regulators approved TransEnterix’s Senhance robot-assisted surgery device for several procedures. Japan’s Ministry of Health, Labor & Welfare granted “shonin” approval to Senhance for laparoscopy for general surgery, gynecology, urology and “certain thoracic procedures,” the Research Triangle Park, N.C.-based company said. “Regulatory approval in Japan is a pivotal milestone for our company, as Japan is…
AdventHealth is first in Florida to use TransEnterix surgical robot for gynecological procedures
Robot-assisted surgery is growing, as new technology enables applications for additional operations. AdventHealth for Women in Florida is an early user of TransEnterix’s Senhance for gynecological procedures.
Robotic piece picking module improves picking accuracy
The Robotic Piece Picking Module is designed to improve accuracy and productivity during the last touch — the point where items of varying sizes and shapes are processed by hand — of the fulfillment process. Traditionally, the last touch has been a manual process, but the Robotic Piece Picking Module completes the automation of the…
TransEnterix Senhance surgical robot gets approved for new procedures
TransEnterix has won expanded indications from the Food and Drug Administration for its Senhance robot-assisted surgical system. The system is now cleared for hernia and gallbladder procedures. There are approximately 760,000 inguinal hernia and 1.2 million laparoscopic cholecystectomy procedures performed annually in the U.S. With this clearance, the system’s total addressable annual procedures in the…
TransEnterix Senhance surgical robot gets approved for new procedures
TransEnterix has won expanded indications from the Food and Drug Administration for its Senhance robot-assisted surgical system. The system is now cleared for hernia and gallbladder procedures. There are approximately 760,000 inguinal hernia and 1.2 million laparoscopic cholecystectomy procedures performed annually in the U.S. With this clearance, the system’s total addressable annual procedures in the…
TransEnterix deals SurgiBot assets for $29m to China’s Great Belief International
TransEnterix (NYSE:TRXC) said today that it agreed to deal its SurgiBot assets to Chinese medtech investment firm Great Belief International for $29 million. The agreement calls for Research Triangle Park, N.C.-based TransEnterix to retain the distribution rights to SurgiBot, which it shelved last year, outside of the U.S. The FDA in April 2016 denied 510(k) clearance for…
TransEnterix CEO Pope, riding high on FDA nod, eyes the laparoscopic surgery market
Share prices for TransEnterix (NYSE:TRXC) have more than doubled since the robot-assisted surgery company won an important clearance from the FDA last week and CEO Todd Pope is optimistic about his companies chances against the undisputed market leader, Intuitive Surgical (NSDQ:ISRG). Morrisville, N.C.-based TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clearance bid last…